Protagonist Therapeutics, Inc. (PTGX)
83.09
+0.10
(+0.12%)
USD |
NASDAQ |
Feb 19, 16:00
83.09
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Research and Development Expense (Quarterly) : 40.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 4.268B |
| ADMA Biologics, Inc. | 1.528M |
| Glaukos Corp. | 43.65M |
| Krystal Biotech, Inc. | 13.23M |
| ACADIA Pharmaceuticals, Inc. | 87.83M |